drug · antibody drug conjugate
patient view →loncastuximab tesirine
Marketedupdated 2mo agoby $ADCT ADC Therapeutics SA🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 5 investigational indications.
indications
investigational
DLBCL
targets
B-lymphocyte antigen CD19
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that